Drug recall · June 20, 2012
Octreotide Acetate Injection recall
Why: Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.
- Lots / codes
Lot # 2006500, Exp 08/31/12
- Quantity
- 6,515 packs
- Company
- Ben Venue Laboratories Inc, Bedford, OH
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- May 1, 2012 · Voluntary: Firm initiated
- Classified
- June 14, 2012
- Reported
- June 20, 2012
- Ended
- August 21, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Octreotide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.